MyFinsight
Home
Blog
About
Contact
Download
Download image
Purchases of short-term
investments
-$153,603K
Net loss
$38,172K
Prepaid expenses and
other assets
-$3,520K
Impairment loss on
long-lived asset
$709K
Accretion of discounts on
short-term investments
-$443K
Amortization of debt discount
and costs
$47K
Loss on foreign
currency exchange
-$38K
Net cash used in
investing activities
$49,625K
Net cash used in
operating activities
$27,145K
Canceled cashflow
$103,978K
Canceled cashflow
$16,465K
Net increase
(decrease) in cash and cash...
$29,531K
Canceled cashflow
$47,239K
Proceeds from sales and
maturities of short-term...
-$103,967K
Purchases of property and
equipment
$11K
Proceeds from issuance of
common stock and...
$70,338K
Payments of deferred
offering costs
-$209K
Stock-based compensation
expense
-$7,757K
Accounts payable
-$5,780K
Income tax and r&d
incentive receivables
$2,189K
Accrued expenses and
other liabilities
-$531K
Accounts receivable
$145K
Depreciation of property and
equipment
-$63K
Net cash provided by
financing activities
-$47,239K
Canceled cashflow
$70,547K
Proceeds from issuance of
common stock in...
-$103,346K
something is missing
-$14,315K
Proceeds from issuance of
common stock from...
-$114K
Payments for tax
withholding in share-based...
$11K
Back
Back
Cash Flow
Altimmune, Inc. (ALT)
Altimmune, Inc. (ALT)
source: myfinsight.com